Rapid review of factors associated with flexible sigmoidoscopy screening use.


Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
03 2019
Historique:
received: 23 08 2018
revised: 04 12 2018
accepted: 24 12 2018
pubmed: 1 1 2019
medline: 17 4 2020
entrez: 1 1 2019
Statut: ppublish

Résumé

Flexible sigmoidoscopy (FS) screening has been shown to reduce colorectal cancer (CRC) incidence and mortality among screened adults. The aim of this review was to identify patient-related factors associated with the screening test's use. We searched PubMed for studies that examined the association between FS screening use and one or more factors. To determine the eligibility of studies, we first reviewed titles, then abstracts, and finally the full paper. We started with a narrow search, which we expanded successively (by adding 'OR' terms) until the number of new publications eligible after abstract review was <1% of the total number of publications. We then abstracted factors from eligible papers and reported the number of times each was found to be positively or negatively associated with FS screening use. We identified 42 papers, most of which reported studies conducted in the United States of America (n = 21, 50%) and the United Kingdom (n = 13, 31%). Across studies, a wide range of factors were examined (n = 123), almost half of which were found to be associated with FS screening use at least once (n = 60). Sociodemographic and health and lifestyle factors that were frequently positively associated with FS screening use included: male gender, higher socioeconomic status and a family history of CRC. Frequently positively associated psychosocial factors included low perceived barriers and high perceived benefits. Findings suggest that future research should focus on developing a theoretical framework of cancer screening behaviour to allow a greater level of consistency and specificity in measuring key constructs.

Identifiants

pubmed: 30597228
pii: S0091-7435(18)30397-9
doi: 10.1016/j.ypmed.2018.12.018
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-18

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Robert S Kerrison (RS)

Research Department of Behavioural Science and Health, University College London, London, UK. Electronic address: robert.kerrison.13@ucl.ac.uk.

Christian von Wagner (C)

Research Department of Behavioural Science and Health, University College London, London, UK.

Trish Green (T)

Hull York Medical School, Allam Medical Building, University of Hull, Hull, UK.

Monica Gibbins (M)

Patient representative, UK.

Una Macleod (U)

Hull York Medical School, Allam Medical Building, University of Hull, Hull, UK.

Mark Hughes (M)

Hull and East Yorkshire Bowel Cancer Screening Centre, Hull and East Yorkshire Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham, UK.

Colin J Rees (CJ)

South Tyneside NHS Foundation Trust, South Tyneside District Hospital, South Shields, Tyne and Wear, UK.

Stephen Duffy (S)

Wolfson Institute, Queen Mary University London, London, UK.

Lesley M McGregor (LM)

Research Department of Behavioural Science and Health, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH